Orthopedics This Week
Berend v. Meneghini: Liposomal Bupivacaine Injectables: Game Changers in Pain Management
The #1 game changer in large joint arthroplasty has been the shift from inpatient surgery to better pain control and outpatient surgery. Liposomal bupivacaine is the poster child of this shift, but is it worth the extra $300? Michael Berend and Michael Meneghini debate this question in an absolutely stellar review of the latest data.